XML 25 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 3,293,209 $ 1,980,693 $ 9,406,715 $ 7,734,897
General and administrative 1,668,258 1,923,375 5,579,549 7,327,906
Total operating expenses 4,961,467 3,904,068 14,986,264 15,062,803
Loss from operations (4,961,467) (3,904,068) (14,986,264) (15,062,803)
Other income (expense):        
Investment income, net 115,992 427,454 423,247 962,197
Interest expense on loan facility (197,080)
Loss on extinguishment of debt (329,158)
Total other income (expense), net 115,992 427,454 423,247 435,959
Net loss $ (4,845,475) $ (3,476,614) $ (14,563,017) $ (14,626,844)
Net loss per common share        
Basic $ (0.34) $ (0.37) $ (1.39) $ (1.64)
Diluted $ (0.34) $ (0.37) $ (1.39) $ (1.64)
Weighted average shares outstanding        
Basic 14,445,240 9,376,872 10,503,367 8,926,114
Diluted 14,445,240 9,376,872 10,503,367 8,926,114